People · Operator
Named in public records as an officer, director or promoter · active 2019–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Akston Biosciences Corp | — | Biotechnology | Series A | $21.7M | $82.7M | 2019 |
James M. Herriman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James M. Herriman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Thomas M. Lancaster | 1 | 1 |
| Lovick E. Cannon | 1 | 1 |
| Todd C. Zion | 1 | 1 |
| Robyn M. Davis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.